PER 1.32% 7.5¢ percheron therapeutics limited

Ann: Investor Presentation, page-3

  1. 2,944 Posts.
    lightbulb Created with Sketch. 448
    • Collaboration to study the neurological aspects of Long COVID-19 (Long Neuro COVID-19) with US based
    researchers led by Dr Igor Koralnik at the Northwestern Medicine Neuro-COVID clinic in Chicago
    o Over 100 million people worldwide reported as having Long Covid – WebMD Nov 18, 2021
    o World first study to assess up to 7,000 plasma proteins in Long COVID-19 patients
    o Collaboration with a global leader in the clinical research of neurological aspects of Long COVID-19
    o Study to look for blood disease markers to assess if amenable to treatment including with ATL1102
    o Retained blood samples from patients tested in the US by leading proteomics group
    o Aim is to generate novel data to identify opportunities for the diagnosis, prognosis and treatment of Long
    Neuro COVID-19 and file for related IP protection
    o First results from testing anticipated shortly

    Shortly sounds promising.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.5¢
Change
-0.001(1.32%)
Mkt cap ! $67.61M
Open High Low Value Volume
7.6¢ 7.7¢ 7.5¢ $38.88K 514.5K

Buyers (Bids)

No. Vol. Price($)
1 39300 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 26315 1
View Market Depth
Last trade - 15.19pm 21/05/2024 (20 minute delay) ?
Last
7.8¢
  Change
-0.001 ( 1.27 %)
Open High Low Volume
7.6¢ 7.8¢ 7.5¢ 112689
Last updated 15.50pm 21/05/2024 ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.